Can the Psychedelic Therapy Model Actually Work in Private Practice?

A practice-design question, not just a training one.

A growing number of clinicians are asking how psychedelic-assisted therapy might eventually fit into their existing practice. But adding psychedelic care isn't like adding another therapeutic modality. Medical screening, prescribing, treatment environments, extended sessions, monitoring, documentation, coordination and follow-up introduce infrastructure most independent practices were never designed to provide.

So perhaps the better question isn't "How do I add psychedelic therapy to my practice?" It's "Can this model actually work in private practice at all?" For clinicians considering this field, it's a practice-design question, not just a training one.

We'll explore

• Which parts of psychedelic care could reasonably happen inside an existing therapy practice?
• What likely requires medical or specialized clinical infrastructure?
• Could therapists keep their patients while partnering with external medical providers?
• What does a collaborative-care model actually look like?
• Who takes responsibility for screening, prescribing and treatment-day monitoring?
• What operational changes would a private practice need to make?
• When does building the infrastructure yourself make sense, and when is partnership the better model?
• Could psychedelic-assisted therapy change the way private mental health practices are structured altogether?

Who it's for

Clinicians considering how psychedelic-assisted therapy might fit their existing practice.

Your hosts

Priya Bains, Lead Psychologist at ATMA CENA Edmonton, and Reverdi Darda, Founder and CEO of ATMA CENA.